Showing results (131-140 of 164) with videos related to

Sort By:
Pageof 17
Atherosclerosis|April 16, 2014
Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13Bente Halvorsen, Linda M Smedbakken, Annika E Michelsen, et al.
Cardiovascular Research|July 5, 2008
Diastolic dysfunction in alveolar hypoxia: a role for interleukin-18-mediated increase in protein phosphatase 2AKarl-Otto Larsen, Birgitte Lygren, Ivar Sjaastad, et al.
Cell Death Discovery|April 13, 2023
A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicineJohanne U Hermansen, Yanping Yin, Aleksandra Urban, et al.
Frontiers in Oncology|December 16, 2022
Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell linesMariaserena Giliberto, Leonardo Miranda Santana, Toril Holien, et al.
Assay and Drug Development Technologies|April 17, 2014
A phenotypic screening approach to identify anticancer compounds derived from marine fungiBernhard Ellinger, Johanna Silber, Anjali Prashar, et al.
European Journal of Immunology|April 23, 2009
Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell populationEirik A Torheim, Lishomwa C Ndhlovu, Frank O Pettersen, et al.
Nature Communications|January 11, 2020
Sensing of HIV-1 by TLR8 activates human T cells and reverses latencyHany Zekaria Meås, Markus Haug, Marianne Sandvold Beckwith, et al.
Frontiers in Immunology|October 25, 2021
Enhanced Gut-Homing Dynamics and Pronounced Exhaustion of Mucosal and Blood CD4+ T Cells in HIV-Infected Immunological Non-RespondersKristina Berg Lorvik, Malin Holm Meyer-Myklestad, Kushi Kushekar, et al.
JCI Insight|January 4, 2024
Evolutionary mode and timing of dissemination of high-grade serous carcinomasAnita Sveen, Bjarne Johannessen, Solveig Mk Klokkerud, et al.
European Journal of Cancer (Oxford, England : 1990)|October 11, 2023
Modified study designs to expand treatment options in personalised oncology: a multistakeholder viewChristophe Le Tourneau, Fabrice André, Åslaug Helland, et al.
Pageof 17